BusinessRodman & Renshaw Reiterates Buy Rating With a $6.00 Price Target for DS Healthcare Group, Inc.By Nasdaq OMXMar 2, 2016, 3:33 PM UTC
BusinessDS Healthcare Announces Transformative Acquisition of Medical Device and Dermatology BusinessesBy Nasdaq OMXFeb 22, 2016, 2:30 PM UTC
